University Of Illinois

CHICAGO — OCT accurately staged skin cancers, allowing for better diagnosis of basal cell carcinoma, prediction of margins and improved planning for Mohs surgery, according to a study presented here.

Patients with head and neck cancer who consumed a diet high in nutrients found to deter chronic disease had a 93% lower likelihood of death due to any cause during the first 3 years after diagnosis, according to study results.

For a growing number of Americans, 12 weeks of paid leave from work after the birth of a child, or to care for an ailing family member, is standard.

For the first time in 3 years, the Women in Medicine Summit will be taking place in person, from Sept. 16 to 17, in Chicago.

The NIH has awarded researchers at the University of Illinois Urbana-Champaign more than $420,000 to develop ultrasound imaging methods to study neurovascular changes underlying Alzheimer’s disease.

Black and Hispanic patients with acute myeloid leukemia who resided in socially disadvantaged neighborhoods had a significantly greater risk for mortality than their white counterparts, according to study results published in Blood.

CHICAGO — During the ASCO Annual Meeting, Healio honored our inaugural Healio Disruptive Innovators in hematology/oncology.

THOROFARE, NJ — Healio is set to host the inaugural hematology/oncology Disruptive Innovators Award Reception during the American Society of Clinical Oncology Annual Meeting. The event will take place on June 4, 2022, at the Hyatt Regency McCormick Place in Chicago, Illinois.

Biomarkers that predict response to inhaled corticosteroid or long-acting muscarinic antagonist treatment may differ between adults and adolescents with uncontrolled mild persistent asthma, researchers reported.

First-line pembrolizumab remained effective, safe and noninferior to chemotherapy among certain patients with PD-L1-positive advanced gastric, gastroesophageal junction cancer, according to follow-up results of the KEYNOTE-062 study.